JFS Wealth Advisors’s Regenxbio RGNX Stock Holding History

JFS Wealth Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-80	Closed	-$3K	–	1852
2021 Q3	$3K	Buy	+80	New	+$2.88K	﹤0.01%	754

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JFS Wealth Advisors's RGNX Position: Q4 2021 in Review

JFS Wealth Advisors sold out of Regenxbio (RGNX) in Q4 2021, closing a stake of 80 shares — an estimated $3K sold.

JFS Wealth Advisors first reported a position in RGNX in Q3 2021 and held it in 1 quarter. The position peaked at $3K in Q3 2021. 172 funds tracked by Wall St. Rank hold RGNX as of Q4 2021.

JFS Wealth Advisors reported no remaining Regenxbio position as of Q4 2021 after selling out during the quarter.
JFS Wealth Advisors sold 80 Regenxbio shares in Q4 2021, an estimated $3K.
JFS Wealth Advisors first reported a position in Regenxbio in Q3 2021 and held it in 1 quarter.
JFS Wealth Advisors's Regenxbio position peaked at $3K in Q3 2021.
172 funds tracked by Wall St. Rank held Regenxbio as of Q4 2021.

Based on JFS Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.